Page last updated: 2024-10-24

carisoprodol and Paraplegia

carisoprodol has been researched along with Paraplegia in 1 studies

Carisoprodol: A centrally acting skeletal muscle relaxant whose mechanism of action is not completely understood but may be related to its sedative actions. It is used as an adjunct in the symptomatic treatment of musculoskeletal conditions associated with painful muscle spasm. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1202)
carisoprodol : A carbamate ester that is the mono-N-isopropyl derivative of meprobamate (which is a significant metabolite). Carisoprodol interrupts neuronal communication within the reticular formation and spinal cord, resulting in sedation and alteration in pain perception. It is used as a muscle relaxant in the symptomatic treatment of musculoskeletal conditions associated with painful muscle spasm.

Paraplegia: Severe or complete loss of motor function in the lower extremities and lower portions of the trunk. This condition is most often associated with SPINAL CORD DISEASES, although BRAIN DISEASES; PERIPHERAL NERVOUS SYSTEM DISEASES; NEUROMUSCULAR DISEASES; and MUSCULAR DISEASES may also cause bilateral leg weakness.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
GREEN, EA1

Other Studies

1 other study available for carisoprodol and Paraplegia

ArticleYear
THE USE OF CARISOPRODOL FOR THE TREATMENT OF SPASTICITY IN THE MENTALLY SUBNORMAL.
    Journal of mental deficiency research, 1964, Volume: 8

    Topics: Ataxia; Athetosis; Carisoprodol; Drug Therapy; Epilepsy; Hemiplegia; Humans; Intellectual Disability

1964